Welcome to our dedicated page for 908 Devices news (Ticker: MASS), a resource for investors and traders seeking the latest updates and insights on 908 Devices stock.
News and updates for 908 Devices Inc. (NASDAQ: MASS) center on its development and deployment of purpose-built handheld devices for chemical analysis in health, safety and defense technology applications. The company reports that its tools are used at the point of need to interrogate unknown and invisible materials and provide quick, actionable answers in situations involving drugs, toxic chemicals and security threats.
Investors and observers following 908 Devices can expect regular news on quarterly financial results, including revenue from product sales, service and contract revenue, recurring revenue tied to its installed base, and non-GAAP measures such as adjusted gross margin and adjusted EBITDA. These updates are often accompanied by commentary on channel mix, recurring revenue trends and strategic focus on handheld chemical analysis tools.
The company also issues news about product developments and launches. Recent announcements describe handheld analyzers that combine FTIR and Raman spectroscopy through proprietary Smart Spectral Processing algorithms, as well as devices designed for rapid field-based identification of unknown bulk solids, liquids, gases and vapors. Such releases highlight capabilities like trace-level detection of drugs, explosives and hazardous materials, wireless connectivity and integration with the 908 Devices Team Leader app.
Another key theme in 908 Devices’ news flow is adoption by government and defense organizations. Public updates have detailed purchases of handheld mass spectrometry and gas identification devices by entities such as the United States Coast Guard and United States Marine Corps for narcotics interdiction, hazardous threat detection and protection of installations and coastal communities.
Corporate governance and investor relations activities also appear in the news stream, including participation in investor conferences, webcasts of earnings calls and changes to the Board of Directors that align with the company’s focus on public health, safety and defense tech. For a comprehensive view of how 908 Devices is executing its strategy, readers can review this evolving news record over time.
908 Devices (Nasdaq: MASS) announced on October 16, 2025 that the United States Marine Corps CBRNE Installation and Protection Program purchased 17 XplorIR handheld gas-identification devices.
The devices will be deployed at Marine Corps installations in the United States and overseas to identify and quantify hazardous gases and vapors, and to support CBRNE and hazardous materials response for federal firefighters, military police, post offices and security augmentation forces.
The XplorIR detects more than 5,000 gas and vapor threats, uploads samples wirelessly to 908 Devices’ Team Leader app for real-time viewing outside hot zones, and complements the Corps’ earlier adoption of the company’s MX908 handheld mass spectrometer for trace-level identification.
908 Devices (NASDAQ: MASS) reported strong Q2 2025 financial results, with total revenue reaching $13.0 million, up 14% year-over-year. The company's recurring revenue grew 28% to $4.7 million, representing 36% of total revenues.
Key operational highlights include record XplorIR device placements, the launch of VipIR analyzer, and the completion of manufacturing consolidation. The company also acquired KAF Manufacturing for $2.75 million and secured a $6.6 million OEM supply commitment. The installed base grew 27% to 3,336 devices.
Despite posting a net loss of $12.9 million, 908 Devices raised its 2025 revenue outlook to $54-56 million, representing 13-17% growth. The company maintains a strong balance sheet with $118.6 million in cash and no debt.
908 Devices (NASDAQ:MASS), a pioneer in handheld chemical analysis devices, has appointed Dr. Brandi Vann to its Board of Directors. Dr. Vann brings over 15 years of experience from the U.S. Department of Defense, where she served as Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense.
The appointment comes as part of the company's strategic refocus on public health, safety, and defense technology. Simultaneously, Jeff George has stepped down from the Board. Dr. Vann's extensive experience includes leadership roles at the Defense Threat Reduction Agency and oversight of critical defense programs.
908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference. The company's management team will deliver a presentation on Wednesday, August 13 at 1:00 PM Eastern Time. Investors can access both the live and archived versions of the presentation through the investor relations section of 908 Devices' website.
908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, before market open.
Management will host a conference call and webcast at 8:30 AM ET to discuss the results. Investors can access the live webcast through the company's website at www.908devices.com, with a replay available within 24 hours after the event.
908 Devices (NASDAQ:MASS) has launched VipIR, a groundbreaking 3-in-1 handheld chemical analyzer designed for field-based identification of unknown bulk substances. The device features Smart Spectral Processing (SSP), a proprietary algorithm that integrates both Raman and FTIR spectroscopy technologies into a single workflow.
VipIR includes an extensive library of over 39,000 chemical spectra and is equipped with built-in Wi-Fi and cellular connectivity. The device is specifically designed for customs, border personnel, and hazardous response teams to identify narcotics, explosives, and toxic chemicals efficiently in the field.
908 Devices (NASDAQ:MASS) partnered with Asylon Robotics to deploy gas-detecting security robots at the 2025 Indianapolis 500, the world's largest single-day sporting event with over 300,000 attendees. The collaboration featured Asylon's DroneDog-2 units equipped with 908 Devices' InterceptIR sensor for real-time air monitoring and surveillance.
The autonomous robots, built on Boston Dynamics' Spot® platform, successfully navigated GPS-denied tunnels beneath the track, maintaining operations through secure mesh communications and Starlink backup. The integration with Asylon's DroneIQ software provided emergency personnel with continuous access to live video, threat alerts, and gas detection readings.
908 Devices (NASDAQ: MASS) announced that the Romanian Customs Authority has successfully deployed 27 MX908 devices across its border operations for enhanced security measures. The handheld mass spectrometers, delivered earlier this year, enable real-time identification of trace chemicals, particularly drugs and explosives. The devices can detect trace levels of substances on vehicles, containers, and packages within seconds, allowing customs officials to make quick, informed decisions during inspections.
The order was secured through 908 Devices' channel partner, MATE-FIN, via an EU Customs Control Equipment Instrument program. The deployment and training were completed in early 2025, strengthening Romania's border security capabilities and its contribution to European Community safety.